All patients undergoing elective coronary artery bypass grafting (CABG) are using some form of platelet aggregation inhibitor preoperatively. Acetylsalicyclic acid (ASA) in monotherapy is the cornerstone in coronary artery disease, but many patients also use a P2Y₁₂ inhibitor due to previous acute coronary syndrome or percutaneous coronary intervention (PCI), or have anticoagulant treatment with vitamin-K antagonists or direct acting oral anticoagulants.

中文翻译：

---

择期心脏手术前停用血小板抑制剂：一个深思熟虑的选择

所有接受选择性冠状动脉旁路移植术 (CABG) 的患者术前都在使用某种形式的血小板聚集抑制剂。单一疗法中的乙酰水杨酸 (ASA) 是冠状动脉疾病的基石，但许多患者也因既往急性冠状动脉综合征或经皮冠状动脉介入治疗 (PCI)使用 P2Y ₁₂抑制剂，或使用维生素 K 拮抗剂或直接作用进行抗凝治疗口服抗凝剂。